These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30036933)

  • 41. Implementation of a formulary management process.
    Karel LI; Delisle DR; Anagnostis EA; Wordell CJ
    Am J Health Syst Pharm; 2017 Aug; 74(16):1245-1252. PubMed ID: 28790076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opinions regarding the Academy of Managed Care Pharmacy dossier submission guidelines: results of a small survey of managed care organizations and pharmaceutical manufacturers.
    Nichol MB; Knight TK; Epstein J; Honda DH; Tretiak R
    J Manag Care Pharm; 2007 May; 13(4):360-71. PubMed ID: 17506602
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Accuracy of pharmacy benefit manager medication formularies in an electronic health record system and the Epocrates mobile application.
    Andrus MR; Forrester JB; Germain KE; Eiland LS
    J Manag Care Spec Pharm; 2015 Apr; 21(4):281-6. PubMed ID: 25803761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of pharmacoeconomic data in making hospital formulary decisions.
    Odedina FT; Sullivan J; Nash R; Clemmons CD
    Am J Health Syst Pharm; 2002 Aug; 59(15):1441-4. PubMed ID: 12166044
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Validating a hospital medicines formulary survey in the Western Pacific Region--a global hospital pharmacy initiative based on the Basel Statements.
    Penm J; Chaar B; Moles R
    Res Social Adm Pharm; 2012; 8(4):298-308. PubMed ID: 22169173
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Formulary submission guidelines for Blue Cross and Blue Shield of Colorado and Nevada. Structure, application and manufacturer responsibilities.
    Langley PC
    Pharmacoeconomics; 1999 Sep; 16(3):211-24. PubMed ID: 10558036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacy formularies in integrated health systems.
    Osborne JA
    J Healthc Resour Manag; 1997; 15(1):18-20. PubMed ID: 10164678
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Developing a national formulary based on a unified payment system in Iran.
    Ahmadi M; Amraei M; Samadbeik M
    Electron Physician; 2017 Jan; 9(1):3623-3629. PubMed ID: 28243416
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Formulary compliance and pharmacy labor costs associated with systematic formulary management strategy.
    Helmons PJ; Kosterink JG; Daniels CE
    Am J Health Syst Pharm; 2014 Mar; 71(5):407-15. PubMed ID: 24534596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formulary decision making: identifying factors that influence P&T committee drug evaluations.
    Segal R; Pathak DS
    Hosp Formul; 1988 Feb; 23(2):174-8. PubMed ID: 10286022
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of pharmacoeconomic data in formulary selection.
    Hatoum HT; Freeman RA
    Top Hosp Pharm Manage; 1994 Jan; 13(4):47-53. PubMed ID: 10130683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expediting Formulary Standardization in a Multihospital Health System Using Layered Learners.
    Hays AJ; Smith JR; Guth RM; Samet SE
    P T; 2018 Mar; 43(3):163-167. PubMed ID: 29491699
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2001.
    Pedersen CA; Schneider PJ; Santell JP
    Am J Health Syst Pharm; 2001 Dec; 58(23):2251-66. PubMed ID: 11763804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physicians' opinions about responsibility for patient out-of-pocket costs and formulary prescribing in two Midwestern states.
    Khan S; Sylvester R; Scott D; Pitts B
    J Manag Care Pharm; 2008 Oct; 14(8):780-9. PubMed ID: 18983207
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of Modified System of Objectified Judgement Analysis (SOJA) methodology on prescribing costs of ACE inhibitors.
    Alabbadi I; Crealey G; Scott M; Baird S; Trouton T; Mairs J; McElnay J
    Clin Drug Investig; 2006; 26(9):485-94. PubMed ID: 17163281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Formulary management at a tertiary-care facility: P&T committee interview.
    Lucas RV; Abramowitz PW
    Hosp Formul; 1988 Feb; 23(2):162-8, 172-3. PubMed ID: 10286021
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical monograph for drug formulary review: erectile dysfunction agents.
    Campbell HE
    J Manag Care Pharm; 2005 Mar; 11(2):151-71. PubMed ID: 15766322
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A P&T Committee's Transition to a Complete Electronic Meeting System-A Multisite Institution Experience.
    Al-Jedai AH; Algain RA; Alghamidi SA; Al-Jazairi AS; Amin R; Bin Hussain IZ
    P T; 2017 Oct; 42(10):641-651. PubMed ID: 29018301
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Web-based survey to assess the perceptions of managed care organization representatives on use of copay subsidy coupons for prescription drugs.
    Nemlekar P; Shepherd M; Lawson K; Rush S
    J Manag Care Pharm; 2013 Oct; 19(8):602-8. PubMed ID: 24074006
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of a limited drug formulary in an adult internal medicine clinic.
    Andersen JM; Ostry S; Uhl HS; Smith RE
    Am J Hosp Pharm; 1982 Jul; 39(7):1184-6. PubMed ID: 7114061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.